Serum alpha1-antitrypsin level and phenotype associated with familial moyamoya disease.
BACKGROUND
Obstructive vascular lesions at the terminal portion of the internal carotid arteries are thought to be the primary and essential lesions in moyamoya disease. The etiology remains unknown. To detect possible mediators of the thickened intima of moyamoya disease, we measured serum alpha-1-antitrypsin (alpha1-AT) levels and characterized the phenotype of patients with familial moyamoya disease.


METHODS
Fifty-six individuals were examined, including 29 patients with moyamoya disease from 14 families. Serum alpha1-AT levels were analyzed by electroimmunoassay and genomic phenotype by isoelectric focusing.


RESULTS
All individuals had a normal alpha1-AT phenotype. The average serum alpha1-AT level in moyamoya disease patients was significantly higher than that of normal individuals, although both were within the normal range.


CONCLUSIONS
These findings suggest that serum alpha1-AT level may be a marker, rather than an etiologic factor, indicating the progression of moyamoya disease.
Amano
Toshiyuki
T
Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, 812-8582 Higashi-ku, Fukuoka, Japan. amano@ns.med.kyushu-u.ac.jp
Inoha
Satoshi
S
Wu
Chun-Ming
CM
Matsushima
Toshio
T
Ikezaki
Kiyonobu
K
D015415:Biomarkers / Q000032:analysis; D005192:Family Health; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007525:Isoelectric Focusing / Q000379:methods; D008297:Male; D009072:Moyamoya Disease / Q000097:blood* / Q000235:genetics; D010641:Phenotype; D000515:alpha 1-Antitrypsin / Q000032:analysis*
D015415:Biomarkers; D000515:alpha 1-Antitrypsin